Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot Applicable 丹蓝仙硼疗氟胶囊治疗地方性氟骨症(肾阳虚证)有效性和安全性的开放临床试验
[Translation] An open clinical trial on the efficacy and safety of Danlanxian Boron Therapeutic Fluoride Capsules in the treatment of endemic skeletal fluorosis (kidney yang deficiency syndrome)
初步探索丹蓝仙硼疗氟胶囊治疗地方性氟骨症(肾阳虚证)有效性和安全性。
[Translation] To preliminarily explore the effectiveness and safety of Danlanxian Boron Therapy Capsules in the treatment of endemic skeletal fluorosis (kidney yang deficiency syndrome).
100 Clinical Results associated with Guiyang Runfeng Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guiyang Runfeng Pharmaceutical Co., Ltd.
100 Deals associated with Guiyang Runfeng Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guiyang Runfeng Pharmaceutical Co., Ltd.